<DOC>
	<DOCNO>NCT02350725</DOCNO>
	<brief_summary>The purpose pilot study investigate pharmacodynamic pharmacokinetic parameter novel furosemide formulation administer subcutaneously compare oral furosemide .</brief_summary>
	<brief_title>Furosemide Pharmacodynamics Pharmacokinetics After Subcutaneous Oral Administration</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<criteria>Written inform consent obtain assessment perform Male female subject ≥18 year age , body weight &lt; 120 kg body mass index ( BMI ) &lt; 30 kg/m2 Female subject must least 2 year postmenopausal Participant must oral furosemide ( 40 mg oid bid ) therapeutic equivalent ( bumetanide 1 mg oid bid ) period 90 day first dose study medication History chronic heart failure accord 2012 ESC guideline presence moderate symptom chronic fluid overload . Chronic fluid overload define presence stable sign symptom heart failure congestion , like dyspnea mild exertion minimal exertion , pulmonary congestion and/or peripheral edema time presentation combination elevate level natriuretic peptide ( NTproBNP &gt; 300 ng/L ) In opinion investigator , able participate study Acute Decompensated Heart Failure ( ADHF ) recent history ADHF significant worsen HF symptom ( within prior 2 week ) Contraindication furosemide Systolic BP ( SBP ) &lt; 90 mm Hg Temperature &gt; 38°C ( oral equivalent ) sepsis active infection require i.v . antimicrobial treatment Serum sodium &lt; 130 mmol/L Serum potassium &lt; 3.0 mmol/L Current plan ( throughout completion study drug infusion ) treatment i.v . therapy , include inotropic agent , vasopressor , levosimendan , nesiritide analogues ; mechanical support ( intraaortic balloon pump , endotracheal intubation , mechanical ventilation , ventricular assist device ) History gastric intestinal surgery may affect absorption oral medication Presence need urinary catheterization Current plan ultrafiltration , hemofiltration , dialysis Impaired renal function define estimate glomerular filtration rate ( eGFR ) admission &lt; 30 mL/min/1.73 m2 calculate per standard local laboratory Administration intravenous radiographic contrast agent within 72 hour prior screen acute contrastinduced nephropathy time screen Major surgery within 30 day prior screen Administration investigational drug implantation investigational device , participation another trial , within 30 day screen Inability follow instruction comply procedures Any surgical medical condition opinion investigator may interfere participation study may affect outcome study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Chronic Fluid Overload</keyword>
</DOC>